Back to search
FDAFDA · Food and drugs·Recall number D-0451-2022

Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03

Published February 2, 2022 · Recall initiated: December 20, 2021

Summary

FDA records drug Class II recall D-0451-2022, published February 2, 2022 and initiated December 20, 2021. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 6,637 500-count bottles; Lot: Lots# 21141983, 21141984 and 21141985, Exp 03/31/2023; Lots# 21142017, 21142018, 21142019, Exp 02/28/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if METOPROLOL SUCCINATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOPROLOL SUCCINATE
Manufacturer
American Health Packaging
Distributor
Nationwide in the USA
UPC
0368001503006
Lot
Lots# 21141983, 21141984 and 21141985, Exp 03/31/2023; Lots# 21142017, 21142018, 21142019, Exp 02/28/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03 recalled?

Yes. FDA published recall D-0451-2022 on February 2, 2022. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOPROLOL SUCCINATE. UPC: 0368001503006.